Radiofrequency ablation combined with systemic chemotherapy in nasopharyngeal carcinoma liver metastases improves response to treatment and survival outcomes

Journal of Surgical Oncology

Volumn 106, Issue 3, 2012, Pages 322-326

  Jin, Ying ^a,b   Cai, Yu Chen ^b   Cao, Ye ^b   Cai, Xiu Yu ^b   Tan, Yu Ting ^b   Shi, Yan Xia ^b   Jiang, Wen Qi ^b  

^a ZHEJIANG CANCER HOSPITAL   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

liver metastases; nasopharyngeal carcinoma; radiofrequency ablation; systemic chemotherapy

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADULT; ARTICLE; BURN; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG DOSE REGIMEN; DRUG FATALITY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LIVER ABSCESS; LIVER FAILURE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NASOPHARYNX CARCINOMA; NEEDLE BIOPSY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT RESPONSE; TUMOR VOLUME;

CARCINOMA; CATHETER ABLATION; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84864687301     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23034     Document Type: Article

References (33)

1. Chang ET, Adami HO,: The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15: 1765-1777.
2. Balm AJ, Plaat BE, Hart AA, et al.: Nasopharyngeal carcinoma: Epidemiology and treatment outcome. Ned Tijdschr Geneeskd 1997; 141: 2346-2350.
3. Liu MT, Hsieh CY, Chang TH, et al.: Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol 2003; 33: 501-508.
4. Ahmad A, Stefani S,: Distant metastases of nasopharyngeal carcinoma: A study of 256 male patients. J Surg Oncol 1986; 33: 194-197.
5. Leung SF, Teo PM, Shiu WW, et al.: Clinical features and management of distant metastases of nasopharyngeal carcinoma. J Otolaryngol 1991; 20: 27-29.
6. Chiesa F, De Paoli F,: Distant metastases from nasopharyngeal cancer. ORL J Otorhinolaryngol Relat Spec 2001; 63: 214-216.
7. Buckley JG, Ferlito A, Shaha AR, et al.: The treatment of distant metastases in head and neck cancerPresent and future. ORL J Otorhinolaryngol Relat Spec 2001; 63: 259-264.
8. Au E, Ang PT,: A phase II trial of 5-fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma. Ann Oncol 1994; 5: 87-89.
9. Tan EH, Khoo KS, Wee J, et al.: Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma. Ann Oncol 1999; 10: 235-237.
10. Ngan RK, Yiu HH, Lau WH, et al.: Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: Report of a phase II study. Ann Oncol 2002; 13: 1252-1258.
11. Van Cutsem E, Nordlinger B, Adam R, et al.: Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer 2006; 42: 2212-2221.
12. Bartlett DL, Berlin J, Lauwers GY, et al.: Chemotherapy and regional therapy of hepatic colorectal metastases: Expert consensus statement. Ann Surg Oncol 2006; 13: 1284-1292.
13. McGhana JP, Dodd GD III:, Radiofrequency ablation of the liver: Current status. AJR Am J Roentgenol 2001; 176: 3-16.
14. Curley SA,: Radiofrequency ablation of malignant liver tumors. Oncologist 2001; 6: 14-23.
15. Wood TF, Rose DM, Chung M, et al.: Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications. Ann Surg Oncol 2000; 7: 593-600.
16. Teo PM, Kwan WH, Lee WY, et al.: Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 1996; 77: 2423-2431.
17. Bensouda Y, Kaikani W, Ahbeddou N, et al.: Treatment for metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis 2011; 128: 79-85.
18. Setton J, Wolden S, Caria N, et al.: Definitive treatment of metastatic nasopharyngeal carcinoma: Report of 5 cases with review of literature. Head Neck 2010; DOI: 10.1002/hed.21608
19. Kemeny N,: Management of liver metastases from colorectal cancer. Oncology (Williston Park) 2006; 20: 1161-1176 (79; discussion 79-80, 85-86).
20. Nguyen CL, Scott WJ, Young NA, et al.: Radiofrequency ablation of primary lung cancer: Results from an ablate and resect pilot study. Chest 2005; 128: 3507-3511.
21. Sato T, Nakagawa T, Kuwayama T, et al.: Pilot study of radiofrequency ablation (RFA) therapy in patients with early breast cancer. Gan To Kagaku Ryoho 2010; 37: 2750-2752.
22. Sutherland LM, Williams JA, Padbury RT, et al.: Radiofrequency ablation of liver tumors: A systematic review. Arch Surg 2006; 141: 181-190.
23. de Baere T, Risse O, Kuoch V, et al.: Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003; 181: 695-700.
24. Jansen MC, van Duijnhoven FH, van Hillegersberg R, et al.: Adverse effects of radiofrequency ablation of liver tumours in the Netherlands. Br J Surg 2005; 92: 1248-1254.
25. Hompes D, Prevoo W, Ruers T,: Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin. Cancer Imaging 2011; 11: 23-30.
26. Abitabile P, Hartl U, Lange J, et al.: Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. Eur J Surg Oncol 2007; 33: 67-71.
27. Siperstein AE, Berber E, Ballem N, et al.: Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg 2007; 246: 559-565 (discussion 65-67).
28. Shigemasa Y, Shimizu T, Wakata K, et al.: Radiofrequency (RF) ablation for liver metastases of colorectal cancer. Gan To Kagaku Ryoho 2010; 37: 2291-2293.
29. Gan YH, Yie SL, Ren ZG, et al.: Prospective randomized trial of RFA and chemotherapy for unresectable small hepatocellular carcinoma. Zhonghua Zhong Liu Za Zhi 2004; 26: 496-498.
30. Lee H, Jin GY, Han YM, et al.: Comparison of survival rate in primary non-small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy. Cardiovasc Intervent Radiol 2011; DOI: 10.1007/s00270-011-0194-y
31. Tangjitgamol S, Manusirivithaya S, Laopaiboon M, et al.: Interval debulking surgery for advanced epithelial ovarian cancer: A cochrane systematic review. Gynecol Oncol 2009; 112: 257-264.
32. Taamma A, Fandi A, Azli N, et al.: Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type. Cancer 1999; 86: 1101-1108.
33. Chua DT, Sham JS, Au GK,: A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma. Oral Oncol 2005; 41: 589-595.